Back
Cassava Sciences, Inc. Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
23
SAVA
Cassava Sciences, Inc.
Last Price:
$2.17
Seasonality Move:
17.85%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atCassava Sciences, Inc. Stock Forecast
-
Is Cassava Sciences, Inc. Stock Undervalued?The current Cassava Sciences, Inc. [SAVA] share price is $2.15. The Score for SAVA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Cassava Sciences, Inc. Stock Go Up Next Year?
Data Unavailable
Cassava Sciences, Inc. Stock Rating
Data Unavailable
Cassava Sciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cassavasciences.com
52-Week Data
52-Week High:
4.98
52-Week Low:
1.15
Prediction Charts
Market Cap:
103.9M
Price in USD:
2.15
Volume:
758K
Beta:
0.90
Technical Analysis
SMA50:
2.74
SMA100:
2.89
SMA200:
2.41
52-Wk Change:
-17.62%
Stock Predictions
-
Is Cassava Sciences, Inc. stock public?Yes, Cassava Sciences, Inc. is a publicly traded company.
-
What is the Cassava Sciences, Inc. stock quote today?The Cassava Sciences, Inc. stock price is 2.15 USD today.
-
How to buy Cassava Sciences, Inc. stock online?You can buy Cassava Sciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-23 | 2.32 | 2.20 | 2.32 | 2.15 |
| Dec-24 | 2.20 | 2.23 | 2.24 | 2.17 |
| Dec-26 | 2.22 | 2.18 | 2.24 | 2.16 |
| Dec-29 | 2.15 | 2.09 | 2.22 | 2.07 |
| Dec-30 | 2.09 | 2.03 | 2.09 | 2.01 |
| Dec-31 | 2.01 | 1.98 | 2.02 | 1.96 |
| Jan-5 | 2.12 | 2.10 | 2.16 | 2.06 |
| Jan-6 | 2.10 | 2.12 | 2.15 | 2.07 |
| Jan-7 | 2.14 | 2.18 | 2.28 | 2.13 |
| Jan-8 | 2.16 | 2.14 | 2.19 | 2.12 |
| Jan-9 | 2.14 | 2.10 | 2.21 | 2.10 |
| Jan-12 | 2.10 | 2.12 | 2.13 | 2.03 |
| Jan-13 | 2.13 | 2.05 | 2.15 | 2.03 |
| Jan-14 | 2.08 | 2.15 | 2.19 | 2.07 |
Cassava Sciences, Inc. Earnings
Data Unavailable
Cassava Sciences, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.54 per share, and a decrease next year of $0.00 per share.
* Cassava Sciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.